CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 12,700 shares, a growth of 12,600.0% from the November 30th total of 100 shares. Based on an average daily trading volume, of 90,800 shares, the days-to-cover ratio is presently 0.1 days.
CSPC Pharmaceutical Group Stock Performance
CSPCY stock opened at C$2.40 on Friday. The company’s 50 day moving average price is C$2.66 and its 200 day moving average price is C$2.83. CSPC Pharmaceutical Group has a fifty-two week low of C$2.25 and a fifty-two week high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The company also recently disclosed a dividend, which was paid on Thursday, December 5th. Stockholders of record on Friday, November 1st were issued a $0.0575 dividend. This is a positive change from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date was Friday, November 1st.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- Retail Stocks Investing, Explained
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- The Significance of Brokerage Rankings in Stock Selection
- How AI Implementation Could Help MongoDB Roar Back in 2025
- How to Find Undervalued Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.